Empower Clinics Raises Further $1.5 Million From Warrant Exercises, Receives License From Health Canada

Empower Clinics (CSE: CBDT) this morning released a company update covering numerous topics, including recent data on warrant exercises, the status of certain applications with Health Canada, and lease arrangements for both its planned health centres in Ontario and its Kai Lab subsidiary. Most notably, the company has seen $1.5 million in proceeds from recent warrant exercises.

While the company headlined that it has now seen over $12.0 million come in the door from the exercise of warrants, the headline is slightly misleading as this figure appears to be a rolling tally, with nearly half of the funds having been received in late 2020 – a different fiscal year for the firm entirely. Since its last update on March 4, the company has seen an additional $1.5 million in funds flow to the company as a result of further warrant exercises.

In relation to the firms medical device establishment license which was filed for on January 21, the company has now been granted a full such license. The license provides the firm with the ability to import, distribute, and sell KAI Saliva, which is a Covid-19 saliva test kit intended for use at home, with Empower focusing on its use for travelers.

With respect to the firms health centre subsidiary, the company has now signed lease agreements for a total of three locations, with build out to commence in the second quarter. Locations are expected to open within the same quarter, with two locations centered in Etobicoke, while the third is in London, Ontario. Further locations are set to be in planning, with each center expected to generate between $2.6 million and $3.6 million in annual revenues.

A lease amendment for its Kai Laboratory in Dallas, Texas, has also been completed, which will enable Empower to proceed with a planned expansion.

Empower Clinics last traded at $0.87 on the CSE.


Information for this briefing was found via Sedar, and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Empower Clinics Reports Run Rate Of US$10.0 Million For Kai Medical Lab Subsidiary

Empower Clinics (CSE: CBDT) this morning announced that one of its subsidiaries, KAI Medical Laboratory,...

Monday, March 8, 2021, 08:32:59 AM

Empower Clinics Reports 2020 Revenues Of $3.2 Million, Net Loss Of $17.1 Million

Empower Clinics (CSE: CBDT) yesterday released its fourth quarter and full year financial results. The...

Friday, July 2, 2021, 09:07:57 AM

Empower Closes $3.0 Million Financing, CEO Enters Into Share Loan Arrangement

Empower Clinics (CSE: CBDT) has evidently closed a much-needed financing as of last night. The...

Friday, January 7, 2022, 08:56:18 AM

Empower Clinics Wraps Up Kai Medical Laboratory Expansion

Empower Clinics Inc. (CSE: CBDT) shared this morning the completion of the expansion of its...

Wednesday, August 4, 2021, 09:37:00 AM

Empower Clinics Enters Pilot Program With Save-On-Foods In BC

Empower Clinics (CSE: CBDT) this morning announced that it will be conducting a pilot program...

Tuesday, July 27, 2021, 08:01:01 AM